This Week In Pharma: Questions On Lilly's Solanezumab Trial Amendments, BioDelivery's BELBUCA

This Week In Pharma: Questions On Lilly's Solanezumab Trial Amendments, BioDelivery's BELBUCA

This week's column presents questions on Lilly's solanezumab trial and BELBUCA. Based on your votes for the more interesting topic, Slingshot Insights will interview an expert and post a transcript.

from Biotech News